Methamphetamine-induced neurotoxicity is attenuated in transgenic mice with a null mutation for interleukin-6

Molecular Pharmacology

Volumn 58, Issue 6, 2000, Pages 1247-1256

  Ladenheim, Bruce ^a   Krasnova, Irina N ^a   Deng, Xiaolin ^a   Oyler, Jonathan M ^a   Polettini, Aldo ^a   Moran, Timothy H ^b   Huestis, Marilyn A ^a   Cadet, Jean Lud ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; DOPAMINE TRANSPORTER; INTERLEUKIN 6; METHAMPHETAMINE; SEROTONIN; SEROTONIN TRANSPORTER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; BRAIN PROTECTION; CAUDATE NUCLEUS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG ABUSE; FRONTAL CORTEX; MOUSE; NERVE DEGENERATION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PUTAMEN; RETICULAR FORMATION; SHORT SURVEY; SUBSTANTIA NIGRA; TRANSGENIC MOUSE;

EID: 0033664304     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.58.6.1247     Document Type: Short Survey

References (51)

1. 2-MPTP on serotoninergic and noradrenergic nerve terminals
2. 3H]PK-11195 binding to activated microglia
3. Antidepressant drugs inhibit a glial 5-hydroxytryptamine transporter in rat brain
4. Cytokine actions in the central nervous system
5. Induction and regulation of interleukin-6 gene expression in rat astrocytes
6. Free radicals and the pathobiology of brain dopamine systems
7. Methamphetamine induces apoptosis in immortalized neural cells: Protection by the protooncogene, bcl-2
8. Attenuation of methamphetamine-induced neurotoxicity in copper/zinc superoxide dismutase transgenic mice
9. Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin-6
10. Interleukin (IL)-6 gene expression in the central nervous system is necessary for fever response to lipopolysaccaride or IL-1 beta: A study on IL-6-deficent mice
11. Reactive gliosis as a consequence of interleukin-6 expression in the brain: Studies in transgenic mice
12. Fas ligand and Fas are expressed constitutively in haman astrocytes and the expression increases with IL-1, IL-6, TNF-α or IFN-γ
13. Amphetamine levels in brain microdialysate, caudate/putamen, substantia nigra and plasma after dosage that produces either behavioral or neurotoxic effects
14. Reactive oxygen intermediates regulate cellular response to apoptotic stimuli: An hypothesis
15. Variability among brain regions in the specificity of 6-hydroxydopamine (6-OHDA)-induced lesions
16. Methamphetamine administration causes overexpression of nNOS in the mouse striatum
17. Null mutation of c-fos causes exacerbation of methamphetamine-induced neurotoxicity
18. Interleukin-6 and interleukin-6 receptor mRNA expression in rat central nervous system
19. Interleukin-6 production in the central nervous system during experimental autoimmune encephalomyelitis
20. Interleukin-6 production in experimental cerebral malaria: Modulation by anticytokine antibodies and possible role in hypergammaglobulinemia
21. Physiological and pathological roles of interleukin-6 in the central nervous system
22. Granulocyte macrophage colony stimulating factor stimulates in vitro proliferation of astrocytes derived from simian mature brains
23. p53-Knockout mice are protected against the long-term effects of methamphetamine on dopaminergic terminals and cell bodies
24. Autoradiographic evidence for methamphetamine-induced striatal dopaminergic loss in mouse brain: Attenuation in Cu/Zn superoxide dismutase transgenic mice
25. 3H]5-HT uptake into glial plasmalemmal vesicles
26. Resistance of neuronal nitric oxide synthase-deficent mice to methamphetamine-induced dopaminergic neurotoxicity
27. Methamphetamine-induced changes in antioxidant enzymes and lipid peroxidation in copper/zinc-superoxide dismutase transgenic mice
28. Dual mechanism of Fas-induced cell death in neuroglioma cells: A role for reactive oxygen species
29. Impaired immune and acute-phase responses in interleukin-6 deficient mice
30. Regional and temporal expression of the peripheral benzodiazepine receptor in MPTP neurotoxicity
31. Clinical manifestations and prognostic futures of acute methamphetamine intoxication
32. Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: Evidence against a role for extracellular dopamine
33. 11C]WIN-35,428
34. L-methamphetamine pharmacokinetics and pharmacodynamics for assessment of in vivo deprenyl-derived 1-methamphetamine
35. Environment-, drug- and stress-induced alterations in body temperature affect the neurotoxicity of substitutes amphetamines in the C57BL/6J mouse
36. 3H]PK 11195 binding in rat cerebral cortex following a local ischaemic lesion
37. Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mice
38. Expression of interleukin 6 in the rat striatum after stereotaxic injection of quinolinic acid
39. L-DOPA potentiation of the serotoninergic deficits due to a single administration of 3,4-methylenedioxymethamphetamine, p-chloroamphetamine or methamphetamine to rats
40. Role of the dopamine in the neurotoxic effects of methamphetamine
41. Localization of interleukin-6 mRNA and interleukin-6 receptor mRNA in rat brain
42. Nitric oxide is a mediator of methamphetamine (METH)-induced neurotoxicity. In vitro evidence from primary cultures of mesencephalic cells
43. Methamphetamine-induced neurotoxicity is associated with increased striatal AP-1 DNA binding activity in mice
44. 11C]WIN-35,428 positron emission tomography studies and direct in vitro determinations
45. Striatal dopamine nerve terminals markers in human, chronic methamphetamine users
46. Hydroxyl radical-mediated oxidation of serotonin: Potential insights into the neurotoxicity of methamphetamine
47. Immune regulation within the central nervous system
48. Methamphetamine-induced expression of interleukin-1 beta mRNA in the rat hypothalamus
49. Expression of interleukin-1 alpha, tumor necrosis factor alpha and interleukin-6 genes in astrocytes under ischemic injury
50. Involvement of cytokines in normal CNS development and neurological diseases: Recent progress and perspectives
51. Serotoninergic sprouting is induced by dopamine-lesion in substantia nigra of adult rat brain